Within the omics lab services market, Repeat held the largest share in 2025, reflecting how ongoing testing programs are embedded in routine research workflows and longitudinal study designs. Demand remains concentrated in repeat service engagements because biopharma companies, academic centers, and clinical research teams often require consistent processing across multiple sample batches, time points, and validation cycles. This recurring need supports steadier laboratory utilization, stronger client retention, and more predictable service volumes than one-time projects, helping Repeat maintain its leadership in the omics lab services market.

One-off is emerging as the fastest-growing segment in the omics lab services market as more users seek targeted analytical support for discrete projects, pilot studies, and early-stage exploratory work. Its momentum is tied primarily to the growing need for flexible access to specialized omics capabilities without committing to longer recurring service arrangements. Compared with repeat engagements, one-off services are better aligned with organizations testing new hypotheses, evaluating limited sample sets, or entering omics applications for the first time, which is accelerating uptake.

Services Segment Analysis: Genomics (Largest Segment) vs Epigenetics (Fastest-Growing Segment)

Genomics accounted for the largest share of the omics lab services market in 2025, aided by its broad applicability across research, drug development, and clinical investigation workflows. its position is maintained through the established role of genomic analysis in identifying variants, characterizing disease mechanisms, and supporting biomarker-related studies, making it a routine service requirement across a wide client base. Because genomics services are often foundational to downstream biological interpretation, they continue to anchor a substantial share of activity in the omics lab services market.

Epigenetics is the fastest-growing services segment in the omics lab services market, driven by rising demand for deeper insight into gene regulation, cellular behavior, and disease-associated biological changes that are not captured by sequence analysis alone. Growth is outpacing alternatives because epigenetics services address expanding research needs in areas where functional context matters, particularly when customers want to understand how environmental, developmental, or disease-related influences affect biological expression. This practical value is increasing adoption and pushing epigenetics forward within the omics lab services market.